Description: Incresync 25 by 30 Mg Tablets are used for the management of type 2 diabetes mellitus. This medication combines two active ingredients that work synergistically to improve glycemic control by enhancing insulin secretion and reducing blood sugar levels. It is suitable for patients who require additional glucose control beyond what is achieved with other medications.
Ingredients:
-
Active Ingredients:
- 25 mg of [First Active Ingredient, e.g., Sitagliptin]
- 30 mg of [Second Active Ingredient, e.g., Metformin]
-
Other Ingredients:
- [List any excipients or additional components, such as binders, fillers, or coloring agents]
Usage Instructions:
-
Dosage: Typically, one tablet daily, or as prescribed by your healthcare provider.
-
Frequency: Once daily.
-
Special Considerations: Take the tablet with food to reduce gastrointestinal side effects. Swallow the tablet whole with a glass of water. Do not crush or chew the tablet.
Benefits:
- Effective in lowering blood glucose levels in patients with type 2 diabetes.
- Combines two mechanisms of action to enhance overall glycemic control.
- May help in managing weight and reducing the risk of diabetes-related complications.
Precautions:
-
Contraindications: Do not use if you are allergic to either of the active ingredients or any other components of the tablet. Not recommended for patients with severe renal impairment or metabolic acidosis.
-
Side Effects: Possible side effects include gastrointestinal symptoms such as nausea, diarrhea, and abdominal discomfort. Rare but serious side effects may include lactic acidosis and severe hypoglycemia.
-
Warnings: Regular monitoring of blood glucose levels and kidney function is essential. Inform your healthcare provider of any other medications or supplements you are taking, as drug interactions may occur. Use with caution in patients with a history of liver disease or pancreatitis.
Storage Instructions:
- Store at room temperature (15°C to 25°C or 59°F to 77°F).
- Keep in a dry place away from light and moisture.
- Keep out of reach of children.
Manufacturer: Jazeera Pharmaceutical Industries (JPI)
